Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 25, 2023 16:00 ET | Source: Recursion Pharmaceuticals

Altitude Lab Relocates to Gateway’s BioHive Hub

SALT LAKE CITY, May 25, 2023 (GLOBE NEWSWIRE) -- Altitude Lab announced today that its incubator program and facility will leave Research Park to grow its operation in the Gateway’s BioHive hub as...
May 16, 2023 08:30 ET | Source: Recursion Pharmaceuticals

Recursion Appoints David Mauro, M.D., Ph.D., as Chief Medical Officer

SALT LAKE CITY, May 16, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has appointed...
May 09, 2023 19:34 ET | Source: Recursion Pharmaceuticals

Recursion firma acuerdos para la adquisición de Cyclica y Valence para fortalecer capacidades de química e IA generativa

SALT LAKE CITY y TORONTO y MONTREAL, May 09, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), una empresa líder de tecnobiología en etapa clínica con la decodificación de biología para la...
May 09, 2023 19:34 ET | Source: Recursion Pharmaceuticals

Recursion conclut des accords pour acquérir Cyclica et Valence en vue de renforcer ses capacités en chimie et de l'IA générative

SALT LAKE CITY, TORONTO et MONTRÉAL, 10 mai 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ : RXRX), une société de biotechnologie au stade clinique de premier plan qui décode la biologie pour...
May 09, 2023 19:34 ET | Source: Recursion Pharmaceuticals

Recursion schließt Übernahmevereinbarungen für Cyclica und Valence zur Stärkung der Fähigkeiten in den Bereichen Chemie und generative KI ab

SALT LAKE CITY und TORONTO und MONTRÉAL, May 10, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), ein führendes, im klinischen Stadium tätiges TechBio-Unternehmen, das die Biologie...
May 09, 2023 19:34 ET | Source: Recursion Pharmaceuticals

Recursion ने केमिस्ट्री और जनरेटिव AI क्षमताओं को सहारा देने हेतु Cyclica and Valence का अधिग्रहण करने के लिए समझौते किए

SALT LAKE CITY और TORONTO और MONTRÉAL, May 10, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), जो कि औषधि की खोज को औद्योगीकृत करने के लिए बाय़ोलॉजी को डिकोड करने वाली एक प्रमुख क्लीनिकल...
May 08, 2023 08:14 ET | Source: Recursion Pharmaceuticals

Recursion Provides Business Updates and Reports First Quarter 2023 Financial Results

Entered into agreements to acquire Cyclica and Valence to bolster digital chemistry and generative AI capabilities in order to further create new chemical composition of matter for novel biological...
May 08, 2023 07:59 ET | Source: Recursion Pharmaceuticals

Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities

SALT LAKE CITY and TORONTO and MONTRÉAL, May 08, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery,...
May 02, 2023 08:30 ET | Source: Recursion Pharmaceuticals

Recursion to Participate in Upcoming Investor Conferences

Salt Lake City, May 02, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery, today announced its...
April 03, 2023 08:30 ET | Source: Recursion Pharmaceuticals

Recursion to Participate in Upcoming Investor Conference

Salt Lake City, April 03, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery, today announced...